why choose us

First received: June 12, 2023

Clinical Trial: The Neuroendocrine Effects of Pioglitazone in Patients With Lung Cancer and Cachexia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Neuroendocrine Effects of Pioglitazone in Patients With Advanced Non-Small-Cell Lung Cancer and Cachexia

Brief Summary: The goal of this clinical trial is evaluate the effect of pioglitazone compared with placebo on skeletal muscle insulin sensitivity in subjects with advanced non-small-cell lung cancer and cachexia.

Read more